Status:
UNKNOWN
Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19
Lead Sponsor:
King Saud University
Conditions:
COVID-19
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
COVID-19 pandemic threatens patients, societies and healthcare systems around the world. The host immunity determines the progress of the disease and its lethality. The associated cytokine storm mainl...
Detailed Description
Subjects: A total of 40 participants will be enrolled in this double-blinded prospective, randomized controlled trial. All participants will sign a written consent after details of the study have been...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV-2 infection
- COVID-19 patient in stable condition (i.e., not requiring ICU admission).
Exclusion
- Tube feeding or parenteral nutrition.
- Pregnant or lactating women
- Admission to ICU \> 24 hours
- participation in another study including any forms of supplementation or disease specific ONS.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04323228
Start Date
September 1 2020
End Date
December 30 2020
Last Update
September 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince Mohamed BinAbdulaziz Hospital
Riyadh, Saudi Arabia, 14214